CRM vs MDB Stock Comparison
CRM currently leads MDB in this stock comparison, with AIQ scores of 64 vs 46. The clearest difference is value.
What is the main difference between CRM and MDB?
CRM leads the current stock comparison as Salesforce, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Salesforce, Inc. vs MongoDB, Inc.
CRM leads
CRM leads by 18 AIQ points, primarily on Value and Momentum, and the lead has widened from 15 points over 30 sessions. Wall Street currently favors MDB on target upside.
Stable: 4 of 6 evidence groups support CRM, its lead is widening, and its signal state is cleanly positive.
Salesforce, Inc.
MongoDB, Inc.
The Algovestiq AIQ Score currently favors CRM over MDB, 64 versus 46 as of Oct 21, 2026. CRM's advantage is driven primarily by stronger value and momentum. CRM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors MDB. 4 of 6 covered evidence groups favor CRM today, and the comparison is rated Stable on stability. CRM lead: Strengthening — the AIQ differential moved from 15 to 18 points over 30 sessions.
Compare Salesforce, Inc. and MongoDB, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare CRM and MDB against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value64 vs 25CRM +39
- Momentum75 vs 52CRM +23
- Quality64 vs 62Even
- Risk Resilience49 vs 49Even
4 of 6 evidence groups favor CRM. CRM’s edge is concentrated in value and momentum.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum -2
No signal started or stopped since the prior session; its 5 active signals are unchanged.
Largest factor move: Momentum +5
No signal started or stopped since the prior session; its 3 active signals are unchanged.
CRM's lead narrowed by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — CRM and MDB both carry a full feed there.
The central trade-off
CRM (Salesforce, Inc.): the stronger current systematic profile, led by value and momentum.
MDB (MongoDB, Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 82.4% against 31.6%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CRMCRM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CRMCRM on combined revenue and EPS growth.
Value
CRMCRM on the peer-relative Value factor, by 39 points.
Momentum
CRMCRM on the Momentum factor, by 23 points.
Lower downside
CRMCRM carries the lower 1-month annualized volatility.
Analyst upside
MDBMDB on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors CRM, analyst targets favor MDB. That disagreement is the most useful thing on this page.
| Measure | CRM | MDB | Note |
|---|---|---|---|
| Implied upside to target | +8.6% | +15.7% | MDB has more room |
| Target dispersion | +47.6% | +54.2% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 21 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor CRM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | CRM | 64 vs 46 |
| Fundamentals | CRM | revenue growth 1.9% vs -1.1%; EPS growth 77% vs -70.9%; TTM ROE 20.2% vs 2%; gross margin 77.3% vs 72.7% |
| Valuation | CRM | Value 64 vs 25 |
| Technicals | CRM | Price vs 50-day 4.2% vs -0.6%; vs 200-day 21.9% vs 8% |
| Risk Resilience | Even | Risk Resilience 49 vs 49 |
| Analyst expectations | MDB | Target upside 8.6% vs 15.7% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CRM and MDB and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 18 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CRM.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20CRM lead: Strengthening — the AIQ differential moved from 15 to 18 points over 30 sessions.
- Today
- CRM +18
- 64 vs 46
- 7 sessions ago
- CRM +21
- 64 vs 43
- 30 sessions ago
- CRM +15
- 54 vs 39
- 90 sessions ago
- CRM +3
- 59 vs 56
The lead changed hands 2 times in this window, most recently on Sep 28 when CRM moved ahead of MDB.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 0 bearish / 1 neutral
Only CRM
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
1 bullish / 1 bearish / 1 neutral, conflicted
Only MDB
- MACD Bearish Crossover — bearish, momentum, short horizon
Both carry 2 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode.
MDB is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved down over the latest session (price -0.27%, AIQ -1 points).
Price and the AIQ Score both moved up over the latest session (price +6.71%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1MDB closes the Value gap — currently 39 points behind, the largest single contributor to CRM's edge.
- 2MDB's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it.
- 3CRM's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
CRM leads on balance| Metric | CRM | MDB |
|---|---|---|
| Revenue growth (YoY) | 1.9% | -1.1% |
| EPS growth (YoY) | 77% | -70.9% |
| Gross margin | 77.3% | 72.7% |
| Operating margin | 21.4% | -0.5% |
| Return on equity (TTM) | 20.2% | 2% |
| Debt to equity | 1.09 | 0.01 |
Performance
CRM leads 4 of 6 windows| Metric | CRM | MDB |
|---|---|---|
| 1 week (5 sessions) | 1.9% | -1.8% |
| 1 month (20 sessions) | 3.9% | -14.4% |
| 3 months (63 sessions) | 48.7% | 20.1% |
| 6 months (126 sessions) | 29.6% | 40.1% |
| Year to date | -8.5% | -12.7% |
| 1 year (252 sessions) | -1.5% | 16.5% |
Technicals
CRM has the stronger structure| Metric | CRM | MDB |
|---|---|---|
| RSI (14) | 62.1 | 56.5 |
| ADX (14) | 18.9 | 13.9 |
| Price vs 50-day | 4.2% | -0.6% |
| Price vs 200-day | 21.9% | 8% |
| Volatility (1M, annualized) | 31.6% | 82.4% |
Risk
Split| Metric | CRM | MDB |
|---|---|---|
| Beta | 0.45 | 1.82 |
| Sharpe ratio | 0.14 | 0.5 |
| Sortino ratio | 0.26 | 0.68 |
| Max drawdown | -43.6% | -48.7% |
| Current drawdown | -8.9% | -22.5% |
| Annualized volatility | 47.6% | 71.1% |
| Value at risk (95%) | -4.1% | -6% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CRM or MDB?
On the Algovestiq AIQ Score, CRM is the stronger of the two as of Oct 21, 2026, scoring 64 against MDB's 46. The edge comes from value and momentum. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CRM or MDB the better buy right now?
CRM carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Stable — 4 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor CRM over MDB?
The composite weights Quality, Value, Momentum and Risk Resilience. CRM leads Value by 39 points; CRM leads Momentum by 23 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CRM or MDB?
Analyst price targets imply +8.6% upside for CRM and +15.7% for MDB, so the Street currently favors MDB. That points the opposite way to the AIQ Score, which favors CRM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CRM or MDB?
CRM is the better-valued of the two on the peer-relative Value factor. CRM on the peer-relative Value factor, by 39 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CRM or MDB?
CRM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CRM or MDB?
CRM on the Momentum factor, by 23 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CRM or MDB?
CRM is the more resilient of the two, so the other name carries the higher downside risk. CRM carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CRM more profitable than MDB?
CRM leads on the comparable margin measures — gross margin 77.3% vs 72.7%; operating margin 21.4% vs -0.5%; ttm roe 20.2% vs 2%.
Is CRM's lead over MDB getting stronger or weaker?
CRM lead: Strengthening — the AIQ differential moved from 15 to 18 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has changed hands 2 times in that window, most recently on 2026-09-28, when CRM moved ahead of MDB.
What would change the CRM vs MDB verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: MDB closes the Value gap — currently 39 points behind, the largest single contributor to CRM's edge; MDB's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it; CRM's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about CRM and MDB?
CRM: 4 bullish / 0 bearish / 1 neutral. MDB: 1 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CRM is Golden Cross Active (bullish, long horizon). On MDB it is Golden Cross Active (bullish, long horizon).
Compare CRM and MDB with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.